Stocktoria
Aurinia Pharmaceuticals Inc. AUPH
Aurinia Pharmaceuticals Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 9,272,162 | $52.9M | 6.69% |
| TWO SIGMA INVESTMENTS, LP | 3,428,705 | $50.8M | 2.47% |
| RENAISSANCE TECHNOLOGIES LLC | 1,663,835 | $24.7M | 1.2% |
| D. E. Shaw & Co., Inc. | 1,572,983 | $23.3M | 1.13% |
| AQR CAPITAL MANAGEMENT LLC | 948,810 | $14.1M | 0.68% |
| CITADEL ADVISORS LLC | 406,674 | $6.0M | 0.29% |
| MILLENNIUM MANAGEMENT LLC | 117,169 | $1.7M | 0.08% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.